Skip to main content
. 2019 Jul 5;11(7):318. doi: 10.3390/pharmaceutics11070318

Figure 4.

Figure 4

(A) Mean plasma and tissue/organ concentrations of tofacitinib and (B) tissue-to-plasma (T/P) ratios of tofacitinib 30 min (n = 4) and 2 h (n = 4) in Sprague-Dawley rats after 1-min intravenous infusion of 10 mg/kg tofacitinib. Data are expressed means ± standard deviations (SD). LI; large intestine, SI; small intestine.